1. Home
  2. GKOS vs W Comparison

GKOS vs W Comparison

Compare GKOS & W Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • W
  • Stock Information
  • Founded
  • GKOS 1998
  • W 2002
  • Country
  • GKOS United States
  • W United States
  • Employees
  • GKOS N/A
  • W N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • W Catalog/Specialty Distribution
  • Sector
  • GKOS Health Care
  • W Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • W Nasdaq
  • Market Cap
  • GKOS 5.8B
  • W 6.2B
  • IPO Year
  • GKOS 2015
  • W 2014
  • Fundamental
  • Price
  • GKOS $103.50
  • W $56.90
  • Analyst Decision
  • GKOS Strong Buy
  • W Buy
  • Analyst Count
  • GKOS 13
  • W 24
  • Target Price
  • GKOS $135.15
  • W $48.00
  • AVG Volume (30 Days)
  • GKOS 903.0K
  • W 4.2M
  • Earning Date
  • GKOS 07-30-2025
  • W 08-04-2025
  • Dividend Yield
  • GKOS N/A
  • W N/A
  • EPS Growth
  • GKOS N/A
  • W N/A
  • EPS
  • GKOS N/A
  • W N/A
  • Revenue
  • GKOS $404,523,000.00
  • W $11,852,000,000.00
  • Revenue This Year
  • GKOS $27.88
  • W $1.80
  • Revenue Next Year
  • GKOS $27.60
  • W $3.54
  • P/E Ratio
  • GKOS N/A
  • W N/A
  • Revenue Growth
  • GKOS 23.92
  • W N/A
  • 52 Week Low
  • GKOS $77.10
  • W $20.41
  • 52 Week High
  • GKOS $163.71
  • W $58.42
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 61.38
  • W 81.30
  • Support Level
  • GKOS $100.92
  • W $50.41
  • Resistance Level
  • GKOS $106.52
  • W $51.62
  • Average True Range (ATR)
  • GKOS 3.30
  • W 2.29
  • MACD
  • GKOS 0.37
  • W 0.33
  • Stochastic Oscillator
  • GKOS 71.27
  • W 93.10

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About W Wayfair Inc.

Wayfair engages in e-commerce in the United States (88% of 2024 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with a handful of stores between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2024, the firm offered more than 30 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, and other home goods. Wayfair was founded in 2002 and began trading publicly in 2014.

Share on Social Networks: